L’Oréal and IDOR sign further collaboration to focus on skin reconstruction
The two companies have been working together since 2012 looking at cell culture and stem cell biology, and the aim of the new collaboration is to evolve the science further, particularly in Brazil.
"Our scientific collaboration with IDOR, especially with Professor Stevens Rehen, illustrates our commitment to predictive evaluation,” says Blaise Didillon, Director of Research & Innovation at L'Oréal Brazil.
“It will open up new possibilities in tissue engineering, to combine 3D biological models with microfluidic technology… IDOR has the necessary skills and equipment to help our Brazilian research centre in this area.”
The French firm started working with IDOR in Brazil four years ago exploring cell culture and stem cell biology and recently they broadened their research scope to tissue engineering and human skin reconstruction, which led to this new venture, with the aim of further developments.
"This partnership with L'Oréal will lead to great developments in Brazil in strategic areas such as regenerative medicine and human tissue biology," adds Dr Jorge Moll Neto, Chairman of IDOR.
Skin focus
Being one of the largest global beauty players, the skin has always been a key focus for L’Oréal and for more than 25 years, the Paris-headquartered firm has been committed to developing predictive methods to evaluate the efficacy and the safety of its ingredients.
Skin reconstruction has always been a focal point in this, and in particular L’Oréal says the Episkin technology is a great tool for developing predictive methods for products safety matters.
The cosmetics maker has already participated in validating several of these methods in Europe and continues to share these developments in countries where regulations are changing in favour of developing alternatives to animal testing, like in Brazil.
The availability of these validated models in Brazil in the future will provide a valuable tool for the local scientific community in the fields of biomedical research and toxicology evaluation.
